Next Generation News and Research

RSS

Varian launches its 325-MS triple-quadrupole liquid chromatograph/mass spectrometer

Varian, Inc. announced today the release of the 325-MS triple-quadrupole LC/MS (liquid chromatograph/mass spectrometer) for the efficient detection and identification of chemical compounds in high-throughput laboratories performing environmental, food safety, and toxicology analyses.

6 Nov 2009

Elysium Internet launches two new online destinations

Elysium Internet, Inc., a next generation Local Internet advertising and digital media Company, today announced the launch of two new online destinations www.PodiatristSites.com and www.LocalPhysician.com as the company seeks to expand its portfolio of health related online destinations.

6 Nov 2009

SpineSmith Partners signs product development agreement with GenOsteo

SpineSmith Partners has signed an initial agreement with GenOsteo, Inc. to co-develop a unique scaffold that mimics the structure of natural cancellous bone.

5 Nov 2009

Arrayit joins federal government to help control health care costs through early diagnosis of diseases

Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs through early diagnosis of diseases.

5 Nov 2009

King Pharmaceuticals announces total revenues of $463M for the third quarter of 2009

King Pharmaceuticals, Inc. announced today that total revenues were $463 million during the third quarter ended September 30, 2009, compared to $388 million in the third quarter of 2008. The Company reported net income of $42 million and diluted earnings per share of $0.17 during the third quarter of 2009, compared to net income of $82 million and diluted earnings per share of $0.34 in the third quarter of the prior year.

5 Nov 2009

Columbia Laboratories reports net revenues of $7.9 million for third quarter 2009

Columbia Laboratories, Inc. today reported financial results for the three- and nine-month periods ended September 30, 2009.

5 Nov 2009

Echo Therapeutics commences its Symphony Transdermal Continuous Glucose Monitoring System clinical study

Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes.

5 Nov 2009

Spinal Modulation completes its $27.4 million Series C financing

Spinal Modulation, Inc. announced today the completion of its $27.4 million Series C financing. Johnson & Johnson Development Corporation (JJDC) joined existing major investors including DeNovo Ventures, ePlanet/DFJ, Kleiner Perkins Caufield & Byers, and MedVenture Associates in this financing. DFJ/InCube Ventures and Raffles Venture Partners are additional new investors.

4 Nov 2009

BioClinica releases financial results for the third quarter of 2009

BioClinica™, Inc., a global provider of clinical trial services, today announced its financial results for the quarter and nine months ended September 30, 2009. The operating results of Phoenix Data Systems (“PDS”) are included in the financial results following the acquisition of PDS that was completed March 24, 2008.

From Clario 4 Nov 2009

Role of robots in the future of healthcare to be discussed during Mobile Robots in Motion conference

GeckoSystems Intl. Corp. today announced that Martin Spencer, GeckoSystems' president and chief executive officer, will discuss the role of robots in the future of healthcare during their "Mobile Robots in Motion" conference in Atlanta, Ga. GeckoSystems is a dynamic leader in the emerging mobile robotics industry, revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

4 Nov 2009

New strategy to eliminate and eradicate malaria unveiled

Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria

4 Nov 2009

superDimension's electromagnetic navigational bronchoscopy device receives AMA Category I CPT code

superDimension, Inc.®, a private company that develops minimally invasive interventional pulmonology devices, announced today that The American Medical Association (AMA) has issued a new Category I CPT® code for the use of the Company's electromagnetic navigational bronchoscopy (ENB) device to navigate to lesions or spots deep in the lungs.

4 Nov 2009

Arrowhead Research updates its shareholders

Arrowhead Research Corporation’s (NASDAQ: ARWR) President and Chief Executive Officer today issued the following letter to the Company’s shareholders.

3 Nov 2009

NIH awards Trevena $7.65M Grand Opportunity grant

Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands announced today that it was awarded a $7.65 million Grand Opportunity (GO) Grant by the office of the director of the National Institutes of Health (NIH). This grant will further fund Trevena’s work to identify and characterize functionally selective biased ligands for a wide range of GPCRs.

3 Nov 2009

Akonni Biosystems announces worldwide launch of their TruTip product line

Akonni Biosystems, a molecular diagnostic (MDx) company focused on providing rapid and highly scalable solutions for research and infectious disease testing, today announced the worldwide launch of their TruTip product line for extracting DNA and RNA from samples with volumes ranging from 100 µl to 1000 µl or more.

3 Nov 2009

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.

3 Nov 2009

Click4Care releases next-generation Utilization Management module for health plan users

Click4Care, a leading provider of care management software for payors, today announced the next-generation Utilization Management (UM) module for its industry leading software platform. By leveraging the UM solution’s extensive configurability, payors and providers can achieve greater levels of productivity while improving clinical, administrative and financial performances.

2 Nov 2009

Arrayit Corporation joins federal government in their efforts to help control health care costs

Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform.

2 Nov 2009

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.

2 Nov 2009

Global health organizations observe World Pneumonia Day; urge governments to take steps to fight pneumonia

Nearly 100 leading global health organizations from around the world joined forces to recognize the first-annual World Pneumonia Day on November 2 and urge governments to take steps to fight pneumonia, the world’s leading killer of young children.

2 Nov 2009

Next Generation News and Research

Varian launches its 325-MS triple-quadrupole liquid chromatograph/mass spectrometer

Elysium Internet launches two new online destinations

SpineSmith Partners signs product development agreement with GenOsteo

Arrayit joins federal government to help control health care costs through early diagnosis of diseases

King Pharmaceuticals announces total revenues of $463M for the third quarter of 2009

Columbia Laboratories reports net revenues of $7.9 million for third quarter 2009

Echo Therapeutics commences its Symphony Transdermal Continuous Glucose Monitoring System clinical study

Spinal Modulation completes its $27.4 million Series C financing

BioClinica releases financial results for the third quarter of 2009

Role of robots in the future of healthcare to be discussed during Mobile Robots in Motion conference

New strategy to eliminate and eradicate malaria unveiled

superDimension's electromagnetic navigational bronchoscopy device receives AMA Category I CPT code

Arrowhead Research updates its shareholders

NIH awards Trevena $7.65M Grand Opportunity grant

Akonni Biosystems announces worldwide launch of their TruTip product line

Interim data from Schering-Plough's narlaprevir Phase IIa study

Click4Care releases next-generation Utilization Management module for health plan users

Arrayit Corporation joins federal government in their efforts to help control health care costs

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Global health organizations observe World Pneumonia Day; urge governments to take steps to fight pneumonia

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News